Antibodies against monocyte chemotactic proteins
CA 2468733 C · Owner: Biogen Ma Inc. · Inventors: Reid, Carl; Garber, Ellen; De Fougerolles, Antonin R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides antibodies that bind to a plurality of .beta.chemokines, particularly monocyte chemotactic proteins MCP-1 MCP-2 and MCP-3. , The invention also provides cells producing the antibodies and methods of , making and using the same.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 27, 2002 and granted June 11, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 27, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 27, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.